KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash from Investing Activities (2016 - 2026)

Fulgent Genetics' Cash from Investing Activities history spans 12 years, with the latest figure at $10.9 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 60.55% to $10.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $94.6 million, a 471.04% increase, with the full-year FY2025 number at $111.4 million, up 290.86% from a year prior.
  • Cash from Investing Activities hit $10.9 million in Q1 2026 for Fulgent Genetics, down from $11.2 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for FLGT hit a ceiling of $53.4 million in Q2 2025 and a floor of -$213.7 million in Q2 2022.
  • Historically, Cash from Investing Activities has averaged -$9.3 million across 5 years, with a median of $9.0 million in 2024.
  • The widest YoY moves for Cash from Investing Activities: up 766.42% in 2024, down 983.74% in 2024.
  • Tracing FLGT's Cash from Investing Activities over 5 years: stood at -$92.6 million in 2022, then skyrocketed by 126.21% to $24.3 million in 2023, then plummeted by 213.12% to -$27.5 million in 2024, then soared by 140.63% to $11.2 million in 2025, then decreased by 1.93% to $10.9 million in 2026.
  • Business Quant data shows Cash from Investing Activities for FLGT at $10.9 million in Q1 2026, $11.2 million in Q4 2025, and $19.1 million in Q3 2025.